Confirmation of antibody titers before and after vaccination with the new coronavirus COVID-19 Antibody Testing
Conditions
Interventions
Sponsors
Haruo Ozaki
Junya Inoue
Sysmex Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Persons who are able to obtain written consent from the person himself/herself or a representative (including family members, relatives, and adult guardians) and who do not meet all of the following gratitude criteria
Exclusion criteria
Exclusion criteria: A facility resident who was judged by the attending physician to be inappropriate for this study. Institutional residents under the age of 65. Institutional residents with a history of bleeding disorders. Institutional residents with a history of vagal reflexes. Facility residents who do not wish to be vaccinated against COVID-19 during their stay in the facility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether subjects can be stratified based on the amount of SARS-CoV-2 S-IgG antibodies before and after COVID-19 vaccination | — |
Secondary
| Measure | Time frame |
|---|---|
| Examination of whether there is an association between stratified subject groups and vaccine type, whether they were infected with the new coronavirus before the booster vaccination, age, gender, and whether they were infected after the booster vaccination. | — |
Contacts
Public ContactHirakawa Hiroyuki
Public Interest Incorporated Association Tokyo Medical Association
Outcome results
None listed